News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

News

August 11, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on August 3, 2022, entitled, “Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma.” continue reading »

Aging | Common Electrocardiogram Measures Are Not Associated With Telomere Length

Aging

August 10, 2022
PRESS RELEASE: A new research paper was published in Aging’s Volume 14, Issue 14, entitled, “Common electrocardiogram measures are not associated with telomere length.” continue reading »

Oncotarget | A Novel Mechanism of Regulation of the Oncogenic Transcription Factor GLI3 by Toll-like Receptor Signaling

News

August 9, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on August 3, 2022, entitled, “A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling.” continue reading »

Oncoscience | SLFN11’s Surveillance Role in Protein Homeostasis

Oncoscience

August 3, 2022
PRESS RELEASE: A new research perspective was published on July 25, 2022, in Volume 9 of Oncoscience, entitled, “SLFN11’s surveillance role in protein homeostasis.” continue reading »

Oncotarget | Chemoradiation Alters PD-L1, CD8+ TILs and Mucin in Rectal Cancer

News

August 2, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 28, 2022, entitled, “Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer.” continue reading »